Large gap with delayed quotes
|
Official
03/10/2026
-
01:04:00
|
Bid
03/09/2026 -
20:59:59
|
Bid Volume |
Ask
03/09/2026 -
20:59:59
|
Ask Volume |
|---|---|---|---|---|
|
78.26
+0.34
(
+0.44% )
|
78.28
|
9,000 |
78.29
|
6,500 |
Analysis date: 06.03.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 27.01.2026.
Interest
Very strong
Very strong
Four stars since 27.02.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 09.12.2025 at a price of 78.24.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 27.02.2026.
4wk Rel Perf
2.23%
2.23%
The four-week dividend-adjusted overperformance versus SP500 is 2.23%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 27.01.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.54%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.90%.
Mkt Cap in $bn
100.11
100.11
With a market capitalization >$8bn, CVS HEALTH is considered a large-cap stock.
G/PE Ratio
1.65
1.65
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
8.29
8.29
The estimated PE is for the year 2028.
LT Growth
10.21%
10.21%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
22
22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
3.45%
3.45%
The twelve month estimated dividend yield represents 28.60% of earnings forecasts.
Beta
18
18
For 1% of index variation, the stock varies on average by 0.18%.
Correlation
0.10
0.10
Stock movements are totally independent of index variations.
Value at Risk
11.99
11.99
The value at risk is estimated at USD 11.99. The risk is therefore 15.39%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002